<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">russjcardiol</journal-id><journal-title-group><journal-title xml:lang="ru">Российский кардиологический журнал</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Cardiology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1560-4071</issn><issn pub-type="epub">2618-7620</issn><publisher><publisher-name>«SILICEA-POLIGRAF» LLC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.15829/1560-4071-2018-1-21-26</article-id><article-id custom-type="elpub" pub-id-type="custom">russjcardiol-2677</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>ORIGINAL ARTICLES</subject></subj-group></article-categories><title-group><article-title>ХАРАКТЕРИСТИКА ТЕЧЕНИЯ ХРОНИЧЕСКОЙ СЕРДЕЧНОЙ НЕДОСТАТОЧНОСТИ И СОСТОЯНИЯ  ОРГАНОВ-МИШЕНЕЙ У БОЛЬНЫХ КАРДИОРЕНАЛЬНЫМ СИНДРОМОМ</article-title><trans-title-group xml:lang="en"><trans-title>CHARACTERISTICS OF THE CHRONIC HEART FAILURE COURSE AND TARGET ORGAN CONDITION   IN CARDIORENAL SYNDROME</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Колегова</surname><given-names>И. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Kolegova</surname><given-names>I. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Колегова Ирина Ивановна — аспирант кафедры пропедевтики внутренних болезней № 2</p></bio><email xlink:type="simple">ikolegova2012@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Чернявина</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Chernyavina</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">anna_chernyavina@list.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Козиолова</surname><given-names>Н. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Koziolova</surname><given-names>N. A.</given-names></name></name-alternatives><bio xml:lang="ru"/><email xlink:type="simple">nakoziolova@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО Пермский государственный медицинский университет им. академика Е.А. Вагнера Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>E.A. Wagner Perm State Medical University of the Ministry of Health</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2018</year></pub-date><pub-date pub-type="epub"><day>08</day><month>03</month><year>2018</year></pub-date><volume>0</volume><issue>1</issue><fpage>21</fpage><lpage>26</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Колегова И.И., Чернявина А.И., Козиолова Н.А., 2018</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="ru">Колегова И.И., Чернявина А.И., Козиолова Н.А.</copyright-holder><copyright-holder xml:lang="en">Kolegova I.I., Chernyavina A.I., Koziolova N.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://russjcardiol.elpub.ru/jour/article/view/2677">https://russjcardiol.elpub.ru/jour/article/view/2677</self-uri><abstract><sec><title>Цель</title><p>Цель. Определить особенности формирования хронической сердечной недостаточности (ХСН) и структурно-функциональной перестройки органов-мишеней у больных ишемической болезнью сердца (ИБС) в сочетании с хронической болезнью почек (ХБП).</p></sec><sec><title>Материал и методы</title><p>Материал и методы. В соответствие с критериями включения и исключения было обследовано 162 пациента ИБС и ХСН II-III функционального класса (ФК), которые были разделены на 2 равные группы: 1-я группа — больные с ХБП, 2-я группа — без ренальной дисфункции. В сравнительном плане в каждой группе были оценены показатели, отражающие особенности формирования ХСН, структурно-функциональное состояние левых отделов сердца, артерий и почек.</p></sec><sec><title>Результаты</title><p>Результаты. Наличие ХБП было взаимосвязано у больных ИБС и ХСН с развитием более выраженных нарушений диастолической функции левого желудочка (p&lt;0,001 по соотношению E/e’ и среднему e’) и увеличением ИММЛЖ (p=0,0043) и при сохраненной ФВ ЛЖ (p&lt;0,001), сопровождающейся более высоким уровнем N-терминального фрагмента натрийуретического пептида (p=0,018). Более значимые нарушения фильтрационной функции почек (p&lt;0,001 по всем показателям) без прогрессирования канальцевых нарушений (p=0,078), более выраженная истинная жесткость артерий (p&lt;0,001 по индексу CAVI1 и индексу аугментации) при увеличении TIMP-1 (p=0,002) регистрировались у больных ИБС и ХСН в сочетании с ХБП.</p></sec><sec><title>Заключение</title><p>Заключение. При наличии ХБП формируется более тяжелая ХСН с сохраненной ФВ ЛЖ и диастолическими нарушениями. Перестройка органов-мишеней у больных ИБС и ХСН при ХБП характеризовалась определенными закономерностями изменений структурно-функционального состояния сердца, артериального русла и почек, одним из механизмов которых явилось нарушение равновесия процессов коллагенолиза в сторону риска фиброза.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Aim</title><p>Aim. To investigate on the specifics of chronic heart failure (CHF) course and functional remodeling of target organs in coronary heart disease (CHD) patients with chronic renal disease (CRD).</p></sec><sec><title>Material and methods</title><p>Material and methods. According to the criteria, 162 patients included, with CHD and CHF II-III functional class (FC), selected to 2 equal groups: group 1 — CRD patients, group 2 — with no renal dysfunction. For comparison, the parameters were evaluated that represent the specifics of CHF pathogenesis, structural and functional condition of the left heart chambers, of arteries and kidneys.</p></sec><sec><title>Results</title><p>Results. The presence of CRD was related to more serious diastolic dysfunction in CHD with CHF patients (p&lt;0,001 for E/e’ and mean e’) and increase of the left ventricle myocardial mass index (p=0,0043) and preserved ejection fraction of the left ventricle (p&lt;0,001), followed by higher level of N-terminal natriuretic peptide (p=0,018). More significant filtration disorders of kidneys (p&lt;0,001 for all values) with no progression of tubular disorders (p=0,078), more prominent arterial stiffness  (p&lt;0,001 by index CAVI1 and augmentation index) with the increase of TIMP-1 (p=0,002) registered in CHD with CHF plus CRD patients.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>хроническая сердечная недостаточность</kwd><kwd>хроническая болезнь почек</kwd></kwd-group><kwd-group xml:lang="en"><kwd>chronic heart failure</kwd><kwd>chronic renal disease</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ronco C, McCullough P, Anker SD, et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010; 31 (6): 703-11. DOI: 10.1093/eurheartj/ehp507</mixed-citation><mixed-citation xml:lang="en">Ronco C, McCullough P, Anker SD, et al. Acute Dialysis Quality Initiative (ADQI) consensus group. Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J. 2010; 31 (6): 703-11. DOI: 10.1093/eurheartj/ehp507</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">De Vecchis R, Baldi C. Cardiorenal syndrome type 2: from diagnosis to optimal management. Ther Clin Risk Manag. 2014; 10: 949-61. DOI: 10.2147/TCRM.S63255.</mixed-citation><mixed-citation xml:lang="en">De Vecchis R, Baldi C. Cardiorenal syndrome type 2: from diagnosis to optimal management. Ther Clin Risk Manag. 2014; 10: 949-61. DOI: 10.2147/TCRM.S63255.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Ishigami J, Grams ME, Naik RP, et al. Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2018; 7 (2). pii: e007209. DOI: 10.1161/JAHA.117.007209.</mixed-citation><mixed-citation xml:lang="en">Ishigami J, Grams ME, Naik RP, et al. Hemoglobin, Albuminuria, and Kidney Function in Cardiovascular Risk: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2018; 7 (2). pii: e007209. DOI: 10.1161/JAHA.117.007209.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Duni A, Liakopoulos V, Rapsomanikis KP, Dounousi E. Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden? Oxid Med Cell Longev. 2017; 2017: 9036450. DOI: 10.1155/2017/9036450.</mixed-citation><mixed-citation xml:lang="en">Duni A, Liakopoulos V, Rapsomanikis KP, Dounousi E. Chronic Kidney Disease and Disproportionally Increased Cardiovascular Damage: Does Oxidative Stress Explain the Burden? Oxid Med Cell Longev. 2017; 2017: 9036450. DOI: 10.1155/2017/9036450.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Carubelli V, Metra M, Lund LH. Negotiating renal dysfunction when treating patients with heart failure. Expert Rev Cardiovasc Ther. 2018; 16 (2): 113-22. DOI: 0.1080/14779072.2018.1422178.</mixed-citation><mixed-citation xml:lang="en">Carubelli V, Metra M, Lund LH. Negotiating renal dysfunction when treating patients with heart failure. Expert Rev Cardiovasc Ther. 2018; 16 (2): 113-22. DOI: 0.1080/14779072.2018.1422178.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Mentz RJ, Kelly JP, von Lueder TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014; 64 (21): 2281-93. DOI: 10.1016/j.jacc.2014.08.036.</mixed-citation><mixed-citation xml:lang="en">Mentz RJ, Kelly JP, von Lueder TG, et al. Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol. 2014; 64 (21): 2281-93. DOI: 10.1016/j.jacc.2014.08.036.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Rutherford E, Mark PB. What happens to the heart in chronic kidney disease? J R Coll Physicians Edinb. 2017; 47 (1): 76-82. DOI: 10.4997/JRCPE.2017.117.</mixed-citation><mixed-citation xml:lang="en">Rutherford E, Mark PB. What happens to the heart in chronic kidney disease? J R Coll Physicians Edinb. 2017; 47 (1): 76-82. DOI: 10.4997/JRCPE.2017.117.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Kadappu KK, Abhayaratna K, Boyd A, et al. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic KidneyDisease: The Value of Left Atrial Function and Volume. J Am Soc Echocardiogr. 2016; 29 (4): 359-67. DOI: 10.1016/j.echo.2015.11.019.</mixed-citation><mixed-citation xml:lang="en">Kadappu KK, Abhayaratna K, Boyd A, et al. Independent Echocardiographic Markers of Cardiovascular Involvement in Chronic KidneyDisease: The Value of Left Atrial Function and Volume. J Am Soc Echocardiogr. 2016; 29 (4): 359-67. DOI: 10.1016/j.echo.2015.11.019.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Sedaghat S, Mattace-Raso FU, Hoorn EJ, et al. Arterial Stiffness and Decline in Kidney Function. Clin J Am Soc Nephrol. 2015; 10 (12): 2190-7. DOI: 10.2215/CJN.03000315.</mixed-citation><mixed-citation xml:lang="en">Sedaghat S, Mattace-Raso FU, Hoorn EJ, et al. Arterial Stiffness and Decline in Kidney Function. Clin J Am Soc Nephrol. 2015; 10 (12): 2190-7. DOI: 10.2215/CJN.03000315.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Kousios A, Kouis P, Panayiotou AG. Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review. Int J Nephrol. 2016; 2016:9498013. DOI: 10.1155/2016/9498013.</mixed-citation><mixed-citation xml:lang="en">Kousios A, Kouis P, Panayiotou AG. Matrix Metalloproteinases and Subclinical Atherosclerosis in Chronic Kidney Disease: A Systematic Review. Int J Nephrol. 2016; 2016:9498013. DOI: 10.1155/2016/9498013.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Wang F, Xiong R, Feng S. Association of Circulating Levels of ADMA with Carotid IntimaMedia Thickness in Patients with CKD: a Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2018 Jan 23; 43 (1): 25-33. DOI: 10.1159/000486743.</mixed-citation><mixed-citation xml:lang="en">Wang F, Xiong R, Feng S. Association of Circulating Levels of ADMA with Carotid IntimaMedia Thickness in Patients with CKD: a Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2018 Jan 23; 43 (1): 25-33. DOI: 10.1159/000486743.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Medić B, Rovčanin B, Basta Jovanović G, et al. Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. Biomed Res Int. 2015; 2015:854070. DOI: 10.1155/2015/854070.</mixed-citation><mixed-citation xml:lang="en">Medić B, Rovčanin B, Basta Jovanović G, et al. Kidney Injury Molecule-1 and Cardiovascular Diseases: From Basic Science to Clinical Practice. Biomed Res Int. 2015; 2015:854070. DOI: 10.1155/2015/854070.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Brankovic M, Akkerhuis KM, van Boven N, et al. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study. Kidney Int. 2017. pii: S0085-2538(17)30729-9. DOI: 10.1016/j.kint.2017.09.013.</mixed-citation><mixed-citation xml:lang="en">Brankovic M, Akkerhuis KM, van Boven N, et al. Patient-specific evolution of renal function in chronic heart failure patients dynamically predicts clinical outcome in the Bio-SHiFT study. Kidney Int. 2017. pii: S0085-2538(17)30729-9. DOI: 10.1016/j.kint.2017.09.013.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou LT, Lv LL, Pan MM, et al. Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis. PLoS One. 2016; 11 (12): e0167334. DOI: 10.1371/journal.pone.0167334.</mixed-citation><mixed-citation xml:lang="en">Zhou LT, Lv LL, Pan MM, et al. Are Urinary Tubular Injury Markers Useful in Chronic Kidney Disease? A Systematic Review and Meta Analysis. PLoS One. 2016; 11 (12): e0167334. DOI: 10.1371/journal.pone.0167334.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
